Currently Viewing:
Currently Reading
Patients With AML Have Significantly Lower Early Mortality at NCI-Designated Cancer Centers
March 17, 2018 – Laura Joszt
This Week in Managed Care: March 16, 2018
March 16, 2018
Despite Increasing Rates of PrEP Usage, Disparities Remain Among African Americans, Latinos
March 16, 2018 – Jaime Rosenberg
COPD Study Fails to Find Model That Can Predict Exacerbations
March 16, 2018 – Allison Inserro
5 Takeaways From the American College of Cardiology Scientific Session
March 16, 2018 – Mary Caffrey
AJMC® in the Press, March 16, 2018
March 16, 2018 – AJMC Staff
What We're Reading: Idaho, CMS Talk Again; Drug Pricing Poll Answers Vary; Senators Want 340B Info
March 16, 2018 – AJMC Staff
Battle Heats Up Over Insurance Stabilization as Abortion Gets Added Into the Mix
March 15, 2018 – Allison Inserro
FDA Takes Step to Reduce Smoking Rates, Proposes Lowering Nicotine Levels in Cigarettes
March 15, 2018 – Jaime Rosenberg

Identifying Differences of Symptoms of Patients With Severe COPD in 3 Countries

Laura Joszt
A study of patients with severe chronic obstructive pulmonary disease (COPD) in Poland, The Republic of Korea, and the United States identified substantial differences in respiratory symptoms and other respiratory illnesses.
There are substantial differences in respiratory symptoms and other respiratory illnesses, according to a study of patients with severe chronic obstructive pulmonary disease (COPD) on 3 continents.

COPD is one of the most common chronic respiratory diseases in the world, and previous research found that COPD mortality increased 11.6% from 1990 to 2015 worldwide. During the same time period, the prevalence of COPD increased 44.2%.

“There are known ethnic differences in respiratory diseases including COPD,” the authors explained in their study published in International Journal of COPD. “Geographic differences in severe COPD have not been widely studied, however.”

The study recruited 828 patients with severe COPD from Poland, The Republic of Korea (South Korea), and the United States. All participants completed a questionnaire and underwent standardized pre-bronchodilator and post-bronchodilator spirometry. Patients from Poland and South Korea were part of the Transcontinental COPD Genetics Study, and patients from the United States were part of the COPD Exacerbations Study. There were also 258 controls from Poland and South Korea who had normal spirometry.

Polish participants tended to be younger, while those from South Korea were almost entirely male, which the authors attributed to the fact that South Korean men have a historically higher rate of smoking than women. The Polish patients also had slightly more severe reductions in lung function.

In all 3 countries, respiratory symptoms and illnesses were assessed with the same questions, including:
  • Do you usually have a cough?
  • Do you usually bring up phlegm from your chest?
  • Does your chest ever sound wheezy or whistling?
  • Have you ever had an attack of wheezing that has made you feel short of breath?
Polish patients had higher rates of usual cough, usual phlegm, and chronic bronchitis, and South Koreans had more frequent attacks of wheezing. The researchers also found that South Koreans had high rates of a history of self-reported tuberculosis and physician-diagnosed asthma; Americans had a higher cumulative smoke exposure and an earlier age of smoking onset; and patients from Poland and the United States both had more frequent occupational exposures to gases or chemical fumes.

“Our results suggest that regional, racial, and environmental differences, as well as differences in diagnostic criteria and comorbidities, could be potential contributors to global COPD heterogeneity,” the authors concluded.

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!